Home ยป Policy reports

Policy reports

  • 14-05-2025

    Joint open letter COGEM and ZKBS on the ERA of new vaccine developments based on samRNAs and VRPs

    In this Joint open letter to the European Commission, the Netherlands Commission on G...

  • 18-10-2024

    The Value of Gene Therapy. A study of the growth, cost and accessibility of gene therapy products

    In this policy report COGEM explores how many gene therapies are in the development p...

  • 10-10-2019

    No rose without thorns

    The current legislation on genetically modified (GM) crops in the European Union (EU)...

  • 21-09-2017

    Editing Human DNA. Moral and social implications of germline genetic modification

    This report is about germline genetic modification (also called germline modification...

  • 15-03-2010

    General Surveillance

    In Europe, authorisation holders for GM crops are required to monitor for the occurre...

  • 09-07-2010

    The status of oligonucleotides within the context of site-directed mutagenesis

    COGEM has been requested by VROM to advise on the question whether an oligonucleotide...

  • 07-10-2009

    Socio-economic aspects of GMO’s

    The minister of Housing, Spatial Planning and the Environment (VROM), Jacqueline Cram...

  • 16-06-2009

    Zinc finger on the pulse: Developments and implications of zinc finger technology

    COGEM continually monitors new techniques that blur the distinction between genetic m...

  • 26-06-2009

    Should EU legislation be updated? Scientific developments throw new light on the process and product approaches

    The EU legislation on genetically modified organisms (GMOs) is no longer in step with...

  • 25-09-2008

    Biological machines? Anticipating developments in synthetic biology

    Synthetic biology is a new research field that seeks to modify existing organisms to ...